Agalsidase beta belongs to the group of medications known as enzyme replacement therapy. It is used as enzyme replacement therapy for people with Fabry disease, which is a genetic disorder where the levels of alpha-galactosidase (an enzyme that breaks down fats) is low or absent.
Available form
Powder
Dosage
Manufacturer
Sanofi-aventis
We won't bore you with the details, but Health Canada requires you to sign in.
By proceeding you agree to our Terms of Use & Privacy Policy
The usual dose of agalsidase beta is 1 mg per kilogram of body weight given every 2 weeks as an infusion into a vein.
Many things can affect the dose of medication that a person needs, such as body weight, other medical conditions, and other medications. If your doctor has recommended a dose different from the ones listed here, do not change the way that you are using the medication without consulting your doctor.
It is important Fabrazyme (Agalsidase-beta) be given exactly as recommended by your doctor. If you miss an appointment to receive agalsidase beta, contact your doctor as soon as possible to reschedule your appointment. If you are receiving Fabrazyme (Agalsidase-beta) at home and miss a dose, contact your doctor.
Vials of Fabrazyme (Agalsidase-beta) are stored in the refrigerator. After prepared for an infusion, Fabrazyme (Agalsidase-beta) should be used immediately.
Do not dispose of medications in wastewater (e.g. down the sink or in the toilet) or in household garbage. Ask your pharmacist how to dispose of medications that are no longer needed or have expired.
Many medications can cause side effects. A side effect is an unwanted response to a medication when it is taken in normal doses. Side effects can be mild or severe, temporary or permanent.
The side effects listed below are not experienced by everyone who takes Fabrazyme (Agalsidase-beta). If you are concerned about side effects, discuss the risks and benefits of Fabrazyme (Agalsidase-beta) with your doctor.
The following side effects have been reported by at least 1% of people taking Fabrazyme (Agalsidase-beta). Many of these side effects can be managed, and some may go away on their own over time.
Contact your doctor if you experience these side effects and they are severe or bothersome. Your pharmacist may be able to advise you on managing side effects.
Although most of the side effects listed below don't happen very often, they could lead to serious problems if you do not seek medical attention.
Check with your doctor as soon as possible if any of the following side effects occur:
Stop taking the medication and seek immediate medical attention if any of the following occur:
Some people may experience side effects other than those listed. Check with your doctor if you notice any symptom that worries you while you are taking Fabrazyme (Agalsidase-beta).
5 mg
Each vial of sterile, nonpyrogenic, white to off-white lyophilized cake or powder, contains agalsidase beta 5.5 mg total amount, which allows for an extractable dose of 5 mg/vial. Nonmedicinal ingredients: mannitol, sodium phosphate monobasic, monohydrate, sodium phosphate dibasic, and heptahydrate. Fabrazyme (Agalsidase-beta) does not contain any preservatives.
35 mg
Each vial of sterile, nonpyrogenic, white to off-white lyophilized cake or powder, contains agalsidase beta 37 mg total amount, which allows for an extractable dose of 35 mg/vial. Nonmedicinal ingredients: mannitol, sodium phosphate monobasic, monohydrate, sodium phosphate dibasic, and heptahydrate. Fabrazyme (Agalsidase-beta) does not contain any preservatives.
Do not use Fabrazyme (Agalsidase-beta) if you are allergic to agalsidase beta or any ingredients of the medication.
There may be an interaction between agalsidase beta and any of the following:
If you are taking any of these medications, speak with your doctor or pharmacist. Depending on your specific circumstances, your doctor may want you to:
An interaction between two medications does not always mean that you must stop taking one of them. Speak to your doctor about how any drug interactions are being managed or should be managed.
Medications other than those listed above may interact with this medication. Tell your doctor or prescriber about all prescription, over-the-counter (non-prescription), and herbal medications you are taking. Also tell them about any supplements you take. Since caffeine, alcohol, the Nicotine from cigarettes, or street drugs can affect the action of many medications, you should let your prescriber know if you use them.
Before you begin using a medication, be sure to inform your doctor of any medical conditions or Allergies you may have, any medications you are taking, whether you are pregnant or breast-feeding, and any other significant facts about your health. These factors may affect how you should use Fabrazyme (Agalsidase-beta).
Allergic and infusion-related reactions: Fabrazyme (Agalsidase-beta) can cause allergic reactions, some of which can be severe. You will receive Fabrazyme (Agalsidase-beta) under close medical supervision, especially at the beginning of treatment.
Most people develop antibodies when treated with enzyme replacement therapy. If you develop antibodies to agalsidase beta, you might experience allergic side effects such as an infusion-related reaction. The antibodies are not likely to stop Fabrazyme (Agalsidase-beta) from working and will decrease with time.
Infusion-related reactions can include chills, fever, increased blood pressure, feeling hot or cold, burning sensations, nausea, vomiting, flushing, fatigue, pain, headache, chest pain, or itchy skin, and usually within the first 3 months of treatment. If you experience an infusion-related reaction, your doctor can decrease the infusion rate or treat the reaction with other medications (e.g., Acetaminophen, Ibuprofen, antihistamines, or corticosteroids).
Heart rhythm: Agalsidase beta can cause changes to the normal rhythm of the heart, including an irregular heartbeat called QT prolongation. QT prolongation is a serious life-threatening condition that can cause fainting, seizures, and sudden death.
If you are at risk for heart rhythm problems (e.g., people with heart failure, Angina, low potassium or magnesium levels), discuss with your doctor how Fabrazyme (Agalsidase-beta) may affect your medical condition, how your medical condition may affect the dosing and effectiveness of Fabrazyme (Agalsidase-beta), and whether any special monitoring is needed.
Pregnancy: Fabrazyme (Agalsidase-beta) should not be used during pregnancy unless the benefits outweigh the risks. If you become pregnant while taking Fabrazyme (Agalsidase-beta), contact your doctor immediately.
Breast-feeding: It is not known if agalsidase beta passes into breast milk. If you are a breast-feeding mother and are taking Fabrazyme (Agalsidase-beta), it may affect your baby. Talk to your doctor about whether you should continue breast-feeding.
Children: The safety and effectiveness of using Fabrazyme (Agalsidase-beta) have not been established for children under 8 years of age.
Seniors: The safety and effectiveness of using Fabrazyme (Agalsidase-beta) have not been established for seniors.
price lookup
Total no. of dose(s)
Manufacturer
Insurance coverage
Dosage
*Actual pricing may differ. Medication is only available by prescription. The cost may be subsidised by your provincial or private health plan.
price details
Total (CAD)
--*
Drug info not available
It’s like having us in your pocket, putting you first in every interaction.
Your medication is delivered to you at no added cost.
Call, text, email—whatever works for you. We’re humans, ready to help.
Discreet with real-time updates. Go about your day, your meds are on the way.
Your region
,
Pocketpills is licensed by
Accreditation No
#
Pharmacy Manager
2025 Pocketpills
Pocketpills is not a pharmacy
or a drug manufacturer
